Literature DB >> 6993549

The hypophosphatemic and hyperkalemic effect of arginine in man.

F Massara, S Martelli, E Cagliero, F Camanni, G M Molinatti.   

Abstract

The effects of a 0.5 g/kg body weight arginine infusion on plasma inorganic phosphate and potassium were examined in 15 normal subjects, and 6 recently diagnosed insulinopenic diabetics. Plasma phosphorus displayed a highly significant (p less than 0.001) fall in normal subjects, with a maximum fall below the baseline of 1.11 +/- 0.15 mg/100 ml or 33 + 3% (mean +/- SE). In addition, there was a highly significant correlation (p less than 0.01) between these falls and the insulin peaks induced by arginine. Plasma potassium levels, on the other hand, displayed a distinct and significant increase in 7 of the 8 subjects studied in this connection. The maximum increase over the baseline was 1.23 +/- 0.17 meq/l or 33 +/- 6% (p less than 0.01). In diabetic patients, arginine too led to a fall in phosphorus. While this was still significant, it was clearly less than in normal subjects: maximum fall = 0.64 +/- 0.09 mg/100 ml or 15 +/- 3%. Plasma potassium increased to a greater extent than in normal subjects: maximum increase = 1.63 +/- 0.21 meq/l or 42 +/- 6%. These findings show that arginine is responsible for a fall in plasma phosphorus that may well be partly related to the insulin response, and an increase in plasma potassium of clinical significance, whose mechanism(s), however, are still obscure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993549     DOI: 10.1007/bf03348247

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  7 in total

1.  EFFECT OF CATIONIC AMINO ACID INFUSION ON POTASSIUM METABOLISM IN VIVO.

Authors:  H W DICKERMAN; W G WALKER
Journal:  Am J Physiol       Date:  1964-02

2.  Splanchnic uptake of glucose, inorganic phosphorus, and potassium after an intravenous glucose load in patients with cirrhosis and in subjects without liver disease.

Authors:  E E GORDON; A CRAIGIE; D N KERR; G R CHERRICK; S SHERLOCK
Journal:  J Lab Clin Med       Date:  1960-06

3.  Forearm metabolism in obesity and its response to intra-arterial insulin. Evidence for adaptive hyperinsulinism.

Authors:  D RABINOWITZ; K L ZIERLER
Journal:  Lancet       Date:  1961-09-23       Impact factor: 79.321

4.  The effect of glycogen deposition on liver phosphorus.

Authors:  N NICHOLS
Journal:  J Clin Invest       Date:  1955-11       Impact factor: 14.808

5.  The relation between amino acids and potassium in isolated rat muscle.

Authors:  N G LEVINSKY; I TYSON; R B MILLER; A S RELMAN
Journal:  J Clin Invest       Date:  1962-03       Impact factor: 14.808

6.  Arginine infusion in dogs. Model for the roles of insulin and glucagon in regulating glucose turnover and free fatty acid levels.

Authors:  A D Cherrington; R Kawamori; S Pek; M Vranic
Journal:  Diabetes       Date:  1974-10       Impact factor: 9.461

7.  Increased urinary phosphate excretion following volume expansion in normal man.

Authors:  T H Steele
Journal:  Metabolism       Date:  1970-02       Impact factor: 8.694

  7 in total
  2 in total

Review 1.  L-Arginine as a potential ergogenic aid in healthy subjects.

Authors:  Thiago S Álvares; Cláudia M Meirelles; Yagesh N Bhambhani; Vânia M F Paschoalin; Paulo S C Gomes
Journal:  Sports Med       Date:  2011-03-01       Impact factor: 11.136

2.  Safety profile of L-arginine infusion in moderately severe falciparum malaria.

Authors:  Tsin W Yeo; Daniel A Lampah; Retno Gitawati; Emiliana Tjitra; Enny Kenangalem; Donald L Granger; J Brice Weinberg; Bert K Lopansri; Ric N Price; David S Celermajer; Stephen B Duffull; Nicholas M Anstey
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.